Study protocol: cohort event monitoring for safety signal detection after vaccination with COVID-19 vaccines in Iran연구 프로토콜: 이란에서 COVID-19 백신 접종 후 안전 신호 감지를 위한 코호트 이벤트 모니터링Article Published on 2022-06-092022-09-11 Journal: BMC Public Health [Category] COVID19(2023년), SARS, 치료기술, 치료제, [키워드] approved articles AZD1222 BBIBP-CorV clinical trial clinical trials Cohort Cohort profile Complete continuous monitoring COVID-19 COVID-19 disease COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines Data collection dose enrolled expansion follow-up period Health Organization Hospitalization implementation include investigated Iran National New Other outcome participant prospective cohort study protocol provided reactogenicity receive required Safety second dose Seven Sinopharm study outcome study outcomes Surveillance target population Template the vaccine vaccination Vaccine Vaccines WHO with COVID-19 World Health Organization [DOI] 10.1186/s12889-022-13575-1 PMC 바로가기 [Article Type] Article
COVID-19 and acute kidney injury in German hospitals 2020독일 병원의 COVID-19 및 급성 신장 손상 2020Article Published on 2022-06-092022-09-11 Journal: PLoS ONE [Category] COVID19(2023년), SARS, 치료기술, [키워드] 95% CI 95%CI Acute kidney injury age AKI bimodal calculated Course COVID-19 COVID-19 diagnosis COVID-19 hospitalization COVID-19 infection denominator diagnosed Diagnosis females Germany healthcare professionals high mortality highest hospital Hospitalization hospitalizations hospitals in-hospital mortality in-hospital mortality rate increase in initial involved less lung involvement male material Mortality multiple organ multiple organs observation period occurred overall mortality pandemic patients peaked performed person year person years Population portal Prognosis proportion provide rate ratio Relative risk remained remuneration renal replacement therapy replacement therapy retrospective risk RRT RT-PCR SARS-CoV-2 pandemic Secondary diagnosis spring SRR Stage therapy was performed while with COVID-19 [DOI] 10.1371/journal.pone.0264510 PMC 바로가기 [Article Type] Article
Mitigation of SARS-CoV-2 transmission at a large public university대규모 공립 대학에서 SARS-CoV-2 전파 완화Article Published on 2022-06-092022-09-12 Journal: Nature Communications [Category] COVID19(2023년), MERS, SARS, 진단, 치료기술, 치료법, [키워드] bypasse Community Compliance death epidemiological expected Health Hospitalization Intervention Laboratory Mitigation Mortality performed populations remained RNA extraction RT-qPCR SARS-CoV-2 SARS-CoV-2 transmission Surveillance target Test transmission of SARS-CoV-2 university viability was reduced [DOI] 10.1038/s41467-022-30833-3 PMC 바로가기 [Article Type] Article
Clinical outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) variant and BA.1/BA.1.1 or BA.2 subvariant infection in Southern California Research Published on 2022-06-082022-10-05 Journal: Nature Medicine [Category] COVID19(2023년), SARS, 임상, 치료기술, [키워드] acute respiratory syndrome Admission B.1.1.529 B.1.617.2 change clinical Clinical outcome coronavirus COVID-19 death Delta delta variant dominant explained hazard ratio healthcare Healthcare system Hospital admission Hospitalization immune protection individual Infection infections intensive care Lower mechanical ventilation occurred omicron outcome progression public health reduced reduced risk risk SARS-CoV-2 SARS-CoV-2 lineage severity Surveillance symptomatic vaccinated against COVID-19 variant [DOI] 10.1038/s41591-022-01887-z [Article Type] Research
Risk of thrombotic events and other complications in anticoagulant users infected with SARS-CoV-2: an observational cohort study in primary health care in SIDIAP (Catalonia, Spain)Observational Study Published on 2022-06-082022-10-05 Journal: BMC primary care [Category] COVID19(2023년), SARS, 임상, [키워드] 95% CI age age and gender analyzed Anticoagulant applied Care Cohort Comorbidity Complication COVID-19 COVID-19 complication database death Diagnosis Electronic health records events Frequency group had more Health higher risk Hospital admission Hospitalization Hospitalized increased risk individuals with COVID-19 Intervention lower risk mortality rate not different OAC Observational cohort study Older oral oral anticoagulant Oral anticoagulants outcome Patient Pneumonia Primary Health Care propensity score matching risk Spain stroke System Thromboembolic event Thromboembolic events thrombotic event Thrombotic events treated with COVID-19 women [DOI] 10.1186/s12875-022-01752-5 PMC 바로가기 [Article Type] Observational Study
Impact of rhinovirus on hospitalization during the COVID-19 pandemic: A prospective cohort study.Paper from the 21st ESCV meeting Published on 2022-06-072022-10-04 Journal: Journal of Clinical Virology [Category] COVID19(2023년), MERS, SARS, 치료기술, [키워드] Adults Analysis Brazil Clinical course Coinfection cough COVID-19 described detect enrolled Fever Follow-up Hospitalization Impact individual individuals with COVID-19 Infection not different objective outcome Outpatient participant Participants pathogen prevalent prospective cohort study Respiratory pathogens Result rhinovirus risk sample collection SARS-CoV-2 screened severity sore throat subject virus was performed with COVID-19 [DOI] 10.1016/j.jcv.2022.105197 PMC 바로가기 [Article Type] Paper from the 21st ESCV meeting
Safety of biological therapy in children and adolescents with severe asthma during the COVID-19 pandemic: a case seriesArticle Published on 2022-06-062022-11-15 Journal: Acta bio-medica : Atenei Parmensis [Category] COVID19(2023년), SARS, 진단, [키워드] allergic Asthma Asymptomatic disease biologic case sery children Clinical characteristics Clinical features collected data Comorbidities control group COVID-19 COVID-19 pandemic demographic data described disease enrolled greater groups Hospitalization Infection Laboratory lack Mild obesity outcome Patient patients patients treated pediatric Pediatric patient positive required Result risk Safety SARS-CoV-2 severe COVID-19 severity tested the disease the SARS-CoV-2 Therapies therapy treated Treatment Two patient [DOI] 10.23750/abm.v93iS3.13073 PMC 바로가기
How Expensive Are Hospitalizations by COVID-19? Evidence From ColombiaArticle Published on 2022-06-042023-06-16 Journal: Value in Health Regional Issues [Category] MERS, [키워드] costs and cost analysis COVID-19 direct medical cost Hospitalization [DOI] 10.1016/j.vhri.2022.04.005 PMC 바로가기
Favipiravir, camostat, and ciclesonide combination therapy in patients with moderate COVID-19 pneumonia with/without oxygen therapy: An open-label, single-center phase 3 randomized clinical trialResearch article Published on 2022-06-032022-10-05 Journal: EClinicalMedicine [Category] 신약개발, 임상, 치료제, [키워드] 95% CI Admission Adverse AMED assigned calculated camostat Characteristics Ciclesonide clinical Clinical finding Clinical management Combination combination therapy comparable COVID-19 COVID-19 infection deaths decrease development discharge Effectiveness enrolled evaluated event Favipiravir finding funding group groups healthcare worker hospital discharge rate Hospital stay Hospitalization Hospitalized Japan Japanese lack less limitation median time Ministry of Health monotherapy no significant difference number Open-label oxygen participant Patient patients patients with moderate Phase 3 phase 3 study Pneumonia positive Primary outcome randomized clinical trial Randomized controlled trial Randomly Registered registry Research SARS-CoV-2 Severe COVID-19 Infection significantly higher significantly lower single-center statistically supported therapy Treatment vaccination Version Welfare [DOI] 10.1016/j.eclinm.2022.101484 [Article Type] Research article
Implicating effector genes at COVID-19 GWAS loci using promoter-focused Capture-C in disease-relevant immune cell types질병 관련 면역 세포 유형에서 프로모터 중심 Capture-C를 사용하여 COVID-19 GWAS 유전자좌에서 이펙터 유전자 관련Article Published on 2022-06-032022-09-11 Journal: Genome Biology [Category] COVID19(2023년), SARS, 변종, [키워드] Adaptive immune response approach attenuate B cell broad spectrum chromatin condition COVID COVID-19 COVID-19 disease COVID-19 disease severity Critical Critical illness death differentially expressed disease disease severity disease-associated e genes element exacerbate functional GART Genes genetic component Genome-wide association study genomic GWAS High-resolution Hospitalization human genetic variation IFNAR2 Immune cell immune cell type immune cells implicated in viral Inflammation interferon interferon response involved life-threatening limit loci magnitude Mild Moderate COVID-19 no symptom OAS1 OAS3 offer Patient PAXBP1 Replication risk SARS-CoV-2 SARS-COV-2 infection target the interferon Therapeutics TNFAIP8L1 variant viral replication [DOI] 10.1186/s13059-022-02691-1 PMC 바로가기 [Article Type] Article